These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38423536)

  • 41. Closed- and Open-loop Deep Brain Stimulation: Methods, Challenges, Current and Future Aspects.
    Ghasemi P; Sahraee T; Mohammadi A
    J Biomed Phys Eng; 2018 Jun; 8(2):209-216. PubMed ID: 29951448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring time domain characteristics of Parkinson's disease using 3D memristive neuromorphic system.
    Siddique MAB; Zhang Y; An H
    Front Comput Neurosci; 2023; 17():1274575. PubMed ID: 38162516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A neurochemical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapies.
    Grahn PJ; Mallory GW; Khurram OU; Berry BM; Hachmann JT; Bieber AJ; Bennet KE; Min HK; Chang SY; Lee KH; Lujan JL
    Front Neurosci; 2014; 8():169. PubMed ID: 25009455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conductive nanogel-interfaced neural microelectrode arrays with electrically controlled in-situ delivery of manganese ions enabling high-resolution MEMRI for synchronous neural tracing with deep brain stimulation.
    Huang WC; Lo YC; Chu CY; Lai HY; Chen YY; Chen SY
    Biomaterials; 2017 Apr; 122():141-153. PubMed ID: 28119154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formal Verification of Deep Brain Stimulation Controllers for Parkinson's Disease Treatment.
    Nawaz A; Hasan O; Jabeen S
    Neural Comput; 2023 Mar; 35(4):671-698. PubMed ID: 36827600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroimaging and electrophysiology meet invasive neurostimulation for causal interrogations and modulations of brain states.
    Gonzalez-Escamilla G; Muthuraman M; Ciolac D; Coenen VA; Schnitzler A; Groppa S
    Neuroimage; 2020 Oct; 220():117144. PubMed ID: 32634593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects.
    Mestre TA; Lang AE; Okun MS
    Mov Disord; 2016 Mar; 31(3):290-6. PubMed ID: 26952118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in neurochemical measurements: A review of biomarkers and devices for the development of closed-loop deep brain stimulation systems.
    Rojas Cabrera JM; Price JB; Rusheen AE; Goyal A; Jondal D; Barath AS; Shin H; Chang SY; Bennet KE; Blaha CD; Lee KH; Oh Y
    Rev Anal Chem; 2020; 39(1):188-199. PubMed ID: 33883813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Battery-Less, Implantable Neuro-Electronic Interface for Studying the Mechanisms of Deep Brain Stimulation in Rat Models.
    Lin YP; Yeh CY; Huang PY; Wang ZY; Cheng HH; Li YT; Chuang CF; Huang PC; Tang KT; Ma HP; Chang YC; Yeh SR; Chen H
    IEEE Trans Biomed Circuits Syst; 2016 Feb; 10(1):98-112. PubMed ID: 25838526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thirty Years of Global Deep Brain Stimulation: "Plus ça change, plus c'est la même chose"?
    Hariz M; Cif L; Blomstedt P
    Stereotact Funct Neurosurg; 2023; 101(6):395-406. PubMed ID: 37844558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Technology of deep brain stimulation: current status and future directions.
    Krauss JK; Lipsman N; Aziz T; Boutet A; Brown P; Chang JW; Davidson B; Grill WM; Hariz MI; Horn A; Schulder M; Mammis A; Tass PA; Volkmann J; Lozano AM
    Nat Rev Neurol; 2021 Feb; 17(2):75-87. PubMed ID: 33244188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson's Disease.
    Molina R; Hass CJ; Cernera S; Sowalsky K; Schmitt AC; Roper JA; Martinez-Ramirez D; Opri E; Hess CW; Eisinger RS; Foote KD; Gunduz A; Okun MS
    Front Hum Neurosci; 2021; 15():633655. PubMed ID: 33732122
    [No Abstract]   [Full Text] [Related]  

  • 53. Deep Brain Stimulation for Obesity: A Review and Future Directions.
    Formolo DA; Gaspar JM; Melo HM; Eichwald T; Zepeda RJ; Latini A; Okun MS; Walz R
    Front Neurosci; 2019; 13():323. PubMed ID: 31057350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On-Off and Proportional Closed-Loop Adaptive Deep Brain Stimulation Reduces Motor Symptoms in Freely Moving Hemiparkinsonian Rats.
    Evers J; Orłowski J; Jahns H; Lowery MM
    Neuromodulation; 2024 Apr; 27(3):476-488. PubMed ID: 37245140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive neuromodulation of cingulo-frontal neural dynamics in major depressive disorder using a brain-computer interface system: A simulation study.
    Fang H; Yang Y
    Front Comput Neurosci; 2023; 17():1119685. PubMed ID: 36950505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlling Clinical States Governed by Different Temporal Dynamics With Closed-Loop Deep Brain Stimulation: A Principled Framework.
    Tinkhauser G; Moraud EM
    Front Neurosci; 2021; 15():734186. PubMed ID: 34858126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fully Closed Loop Test Environment for Adaptive Implantable Neural Stimulators Using Computational Models.
    Stanslaski S; Farooqi H; Sanabria DE; Netoff TI
    J Med Device; 2022 Sep; 16(3):034501. PubMed ID: 35646224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skin Conductance as a Viable Alternative for Closing the Deep Brain Stimulation Loop in Neuropsychiatric Disorders.
    Wickramasuriya DS; Amin MR; Faghih RT
    Front Neurosci; 2019; 13():780. PubMed ID: 31447627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real-time removal of stimulation artifacts in closed-loop deep brain stimulation.
    Nie Y; Guo X; Li X; Geng X; Li Y; Quan Z; Zhu G; Yin Z; Zhang J; Wang S
    J Neural Eng; 2021 Dec; 18(6):. PubMed ID: 34818629
    [No Abstract]   [Full Text] [Related]  

  • 60. Closed-loop programming using external responses for deep brain stimulation in Parkinson's disease.
    Sasaki F; Oyama G; Sekimoto S; Nuermaimaiti M; Iwamuro H; Shimo Y; Umemura A; Hattori N
    Parkinsonism Relat Disord; 2021 Mar; 84():47-51. PubMed ID: 33556765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.